Anhui Wanbang Pharmaceutical Technology Co Ltd. Stock Analysis 301520.SZ

Anhui Wanbang Pharmaceutical Technology Co., Ltd. engages in the provision of professional pharmaceutical research and development outsourcing services for pharmaceutical companies and other pharmaceutical research and development institutions through contracts. The company is headquartered in Hefei, Anhui and currently employs 370 full-time employees. The company went IPO on 2023-09-25. The firm mainly provides professional pharmaceutical research and development outsourcing services to pharmaceutical companies and other pharmaceutical research and development institutions. The firm's services mainly include pharmaceutical research services such as generic drug development and consistency evaluation services, as well as clinical research services such as clinical trial operations, clinical trial site management, biological sample analysis, data management and statistical analysis. The firm mainly operates its businesses in the domestic market.